Biotech News
Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update
ir.tayshagtx.com2026-05-06 15:13 EST
Dosed multiple Rett syndrome patients in REVEAL pivotal trial of TSHA-102, with enrollment advancing across multiple sites; on track to complete dosing in Q2 2026 Received FDA clearance to initiate ASPIRE trial in three patients aged 2 to